Contact us in British Columbia and Yukon


Crohn’s and colitis are much more manageable when we share our experiences with each other. Education events, chapter meetings, and fundraising activities are great opportunities to meet people who are living with IBD, their families and friends, and to learn of local resources and health professionals to support you and your family.

Leadership Giving Officer, Western Canada
Susan Hampton

604-314-1151

Coordinator, Development and Community Engagement, BC/Yukon/SK
Mishal Tahir

778-879-3473
1-800-513-8202

Coordinator, Development & Community Engagement, Southwest BC
Mishal Tahir

778-879-3473
1-800-513-8202

Gutsy Learning Sereies logo on background of a public speaker

Navigating Crohn's and colitis in the Workplace: Empowering Tools for Disclosure and Accommodations

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual
 • 
A family gathered around a child looking at a tablet

Ask the Expert: Caregiving and IBD

Are you supporting someone with inflammatory bowel disease (IBD), or living with IBD while providing care to someone else? You're not alone.  Join our free Ask the Expert event designed to ...

 • 
Virtual - Online
 • 
Remember to bookmark this page.

British Columbia & Yukon Office

2110-439 University Avenue
Toronto, ON M5G 1Y8

bc@crohnsandcolitis.ca 416-920-5035 or 1-800-387-1479

Search by Postal Code

News

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

“You don’t need to be superhuman”: How a small-town hockey player made it to the NCAA in the face of Crohn’s disease

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

 46 47 48 49 50 51 52 53 54 55